| 溶解性 | DMSO |
| 存贮条件 | 储存温度-20°C |
| 产品介绍 | MBX-2982是口服活性GPR119选择性激动剂。 |
| 生化机理 | MBX-2982 is a potential first-in-class treatment for type 2 diabetes that targets G protein-coupled receptor 119 (GPR119), a receptor that interacts with bioactive lipids known to stimulate glucose-dependent insulin secretion. Preclinical data indicate that MBX-2982 is a potent selective orally-active GPR119 agonist that functions through a unique dual mechanism of action. First, it acts directly on the beta cell to increase insulin secretion. In addition, MBX-2982 stimulates release of the incretin GLP-1 from the gut. This dual action is unique and may offer improved glucose homeostasis over existing diabetes therapies, with potential for weight loss and improved islet health. |
| 别名 | MBX 2982;MBX2982；5-乙基-2-[4-[4-[[[4-(1H-四氮唑-1-基)苯基]氧基]甲基]噻唑-2-基]哌啶-1-基]嘧啶;MBX 2982;MBX2982；5-Ethyl-2-[4-[4-[[[4-(1H-tetrazol-1-yl)phenyl]oxy]methyl]thiazol-2-yl]piperidin-1-yl]pyrimidine |
MBX-2982
MBX-2982 （订货以英文为准）
编号：M127623
CAS号：1037792-44-1
分子式：C22H24N8OS
分子量：448.54
| 产品名称 | MBX-2982 |
| 中文名称 | MBX-2982 |
| CAS号 | 1037792-44-1 |
| 分子式（M.F.） | C22H24N8OS |
| 分子量（M.W.） | 448.54 |
| 储存条件 | -20°C储存 |
搜索质检报告(COA)
搜索MSDS
相关产品
¥ 2606.00
356234-5mL
¥ 81.00
P0017C-500mL
¥ 120.00
P0017B-250mL
¥ 328.00
W4201820250-25mL
¥ 450.00
G769603-(11X10ml)/EA
¥ 450.00
O769595-(11X10ml)/EA
¥ 450.00
Y769597-(11X10ml)/EA
¥ 450.00
B769593-(11X10ml)/EA
党沛 
